专利检索 ap:("Gilead Sciences, Inc." OR "Novo Nordisk A/S") AND inv:"Gangadharan Mani Subramanian" 第 1 页

1.

发明公开
Combination Therapy for Treatment of Liver Disease 审中-公开

公开(公告)号：US20240307502A1

公开(公告)日：2024-09-19

申请号：US18673424

申请日：2024-05-24

申请人： Gilead Sciences, Inc. , Novo Nordisk A/S

发明人： Constantine Stephen Djedjos , Bryan John McColgan , Robert Paul Myers , Gangadharan Mani Subramanian , Lene Melchiorsen , Morten Hansen

IPC分类号： A61K38/26 , A61K9/00 , A61K31/4439 , A61K31/519 , A61P1/16 , A61P3/04 , A61P3/10

CPC分类号： A61K38/26 , A61K9/0019 , A61K9/0053 , A61K31/4439 , A61K31/519 , A61P1/16 , A61P3/04 , A61P3/10

摘要： The present disclosure relates to a method of treating non-alcoholic steatohepatitis (NASH) comprising administering to a subject with NASH a combination therapy comprising semaglutide, firsocostat, and/or cilofexor.